Expensive gene therapy receives its first patient in a commercial treatment – Digital Trends
Digital Trends |
Expensive gene therapy receives its first patient in a commercial treatment
Digital Trends A patient with an extremely rare immune disease has been treated with commercial gene therapy for the first time, GlaxoSmithKline, the company behind the therapy, told MIT Technology Review on Tuesday. The treatment come almost a year after the therapy … |
